Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded related topic 'Rheumatoid arthritis' and a MedlinePlus Genetics link. Updated PubMed note to reflect automatic population and revision to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding lapse notice from the page. The prior notice warned that information might not be up to date due to appropriations and NIH operations.SummaryDifference0.1%

- Check28 days agoChange DetectedRheumatoid arthritis related topic and MedlinePlus Genetics topic were removed from the page's related topics section.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page's related resources section; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedUpdated citation to reflect formal October 2025 issue publication; removed “Online ahead of print” status and adjusted publication date and minor author/name formatting.SummaryDifference0.1%

- Check63 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference0.8%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.